Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Bromodomain inhibitors and therapeutic applications
G. Bharath Kumar, Ming‐Ming Zhou
Current Opinion in Chemical Biology (2023) Vol. 75, pp. 102323-102323
Open Access | Times Cited: 30

Showing 1-25 of 30 citing articles:

Anticancer benzimidazole derivatives as inhibitors of epigenetic targets: a review article
Nardin Wagih, Islam M. Abdel-Rahman, Nawal El‐Koussi, et al.
RSC Advances (2025) Vol. 15, Iss. 2, pp. 966-1010
Open Access | Times Cited: 2
Epigenetic Targets and Their Inhibitors in the Treatment of Idiopathic Pulmonary Fibrosis
Xiaohui Miao, Pan Liu, Yangyang Liu, et al.
European Journal of Medicinal Chemistry (2025) Vol. 289, pp. 117463-117463
Closed Access | Times Cited: 2
Hypoxia-Inducible Factor-Dependent and Independent Mechanisms Underlying Chemoresistance of Hypoxic Cancer Cells
Peter Wai Tik Lee, Lina Rochelle Koseki, Takao Haitani, et al.
Cancers (2024) Vol. 16, Iss. 9, pp. 1729-1729
Open Access | Times Cited: 4
Design, synthesis, and antitumor evaluation of triazolopyridine derivatives as novel inhibitors for BRD4
Jingying Liu, H.M. Zhang, Cheng Wang, et al.
European Journal of Medicinal Chemistry (2025) Vol. 285, pp. 117272-117272
Closed Access
Synergistic enhancement of PARP inhibition via small molecule UNI66-mediated suppression of BRD4-dependent transcription of RAD51 and CtIP
Enkhzul Amarsanaa, Minwoo Wie, Unbeom Shin, et al.
NAR Cancer (2025) Vol. 7, Iss. 2
Open Access
Non-oncogene dependencies: Novel opportunities for cancer therapy
Tiziana Di Marco, Mara Mazzoni, Angela Greco, et al.
Biochemical Pharmacology (2024) Vol. 228, pp. 116254-116254
Closed Access | Times Cited: 3
Discovery of the First BRD4 Second Bromodomain (BD2)-Selective Inhibitors
Junhua Li, Qingqing Hu, Run Zhu, et al.
Journal of Medicinal Chemistry (2024)
Closed Access | Times Cited: 3
Distinct Histone H3 Lysine 27 Modifications Dictate Different Outcomes of Gene Transcription
Tsuyoshi Konuma, Ming‐Ming Zhou
Journal of Molecular Biology (2023) Vol. 436, Iss. 7, pp. 168376-168376
Closed Access | Times Cited: 9
Targeting lysine acetylation readers and writers
Ming‐Ming Zhou, Philip A. Cole
Nature Reviews Drug Discovery (2024)
Closed Access | Times Cited: 2
Epigallocatechin-3-gallate inhibit the protein arginine methyltransferase 5 and Enhancer of Zeste homolog 2 in breast cancer bothin vitroandin vivo
Kirankumar Nalla, Biji Chatterjee, Jagadeesha Poyya, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access | Times Cited: 1
mRNA Display in Cell Lysates Enables Identification of Cyclic Peptides Targeting the BRD3 Extraterminal Domain
Catherine A. Hurd, Jacob T. Bush, Andrew J. Powell, et al.
Angewandte Chemie International Edition (2024) Vol. 63, Iss. 38
Open Access | Times Cited: 1
The interconnection between periodontitis and HIV-1 latency: Molecular mechanisms and therapeutic insights
Tengyi Zheng, Fangguo Lu, Tiange Cai, et al.
International Immunopharmacology (2024) Vol. 143, pp. 113402-113402
Closed Access | Times Cited: 1
Structure-Based Rational Design and Evaluation of BET-Aurora Kinase Dual-Inhibitors for Treatment of Cancers
Kaikai Lyu, Ying Ren, Jie Mou, et al.
Journal of Medicinal Chemistry (2024) Vol. 68, Iss. 2, pp. 1344-1364
Closed Access | Times Cited: 1
BET Protein Inhibitor JQ1 Ameliorates Experimental Peritoneal Damage by Inhibition of Inflammation and Oxidative Stress
Vanessa Marchant, Flavia Trionfetti, Lucía Tejedor-Santamaría, et al.
Antioxidants (2023) Vol. 12, Iss. 12, pp. 2055-2055
Open Access | Times Cited: 3
Design, synthesis, and evaluation of 4-(3-(3,5-dimethylisoxazol-4-yl)benzyl)phthalazin-1(2H)-one derivatives: potent BRD4 inhibitors with anti-breast cancer activity
Yingpeng Li, Xinhong Chu, Yin Yu, et al.
Frontiers in Pharmacology (2023) Vol. 14
Open Access | Times Cited: 3
Discovery of novel bromodomain-containing protein 4 (BRD4-BD1) inhibitors combined with 3d-QSAR, molecular docking and molecular dynamics in silico
Rong Liu, XiaoDie Chen, Jiali Li, et al.
Journal of Biomolecular Structure and Dynamics (2024), pp. 1-18
Closed Access
mRNA display in cell lysates enables identification of cyclic peptides targeting the BRD3 extraterminal domain
Catherine A. Hurd, Jacob T. Bush, Andrew J. Powell, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access
Ellagic acid: a potential inhibitor of enhancer of zeste homolog-2 and protein arginine methyltransferase-5
Kirankumar Nalla, Biji Chatterjee, Jagadeesha Poyya, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access
mRNA Display in Cell Lysates Enables Identification of Cyclic Peptides Targeting the BRD3 Extraterminal Domain
Catherine A. Hurd, Jacob T. Bush, Andrew J. Powell, et al.
Angewandte Chemie (2024) Vol. 136, Iss. 38
Open Access
Recent progress in the development of therapies targeting molecular factors in breast cancer
Dominika Kunachowicz, Monika Birska, Karolina Kłosowska, et al.
Farmacja Polska (2024) Vol. 80, Iss. 3, pp. 189-204
Open Access
中药和天然产物精准调控自噬的策略及其在神经退行性疾病模型中的应用
Dong Yu, Jiahong Lu
Scientia Sinica Vitae (2024)
Closed Access
Identification of Novel Bromodomain-Containing Protein 4 (BRD4) Binders through 3D Pharmacophore-Based Repositioning Screening Campaign
Ester Colarusso, Erica Gazzillo, Eleonora Boccia, et al.
Molecules (2024) Vol. 29, Iss. 17, pp. 4025-4025
Open Access
Chemical Targeting of Histone Acetyltransferases
Qi Liu, Aimee L. Qi, Adam D. Durbin, et al.
Royal Society of Chemistry eBooks (2024), pp. 266-306
Closed Access
Drug Discovery for Chromatin Readers, Writers, Erasers, Remodelers and Epitranscriptomic Targets

Royal Society of Chemistry eBooks (2024)
Closed Access
Menin Inhibitors: Discovery, Development and Clinical Translation
Dong Chen, Joshua Ray, Tomasz Cierpicki, et al.
Royal Society of Chemistry eBooks (2024), pp. 596-622
Closed Access
Page 1 - Next Page

Scroll to top